Stay updated on Ublituximab in RMS: Clinical Trial
Sign up to get notified when there's something new on the Ublituximab in RMS: Clinical Trial page.
Latest updates to the Ublituximab in RMS: Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoChange DetectedPublications note updated to indicate items are automatically filled in from PubMed and that PubMed is a public database; Revision: v3.3.2.SummaryDifference0.1%
- Check19 days agoChange DetectedRemoved the government funding status notice banner. Core study information, eligibility criteria, endpoints, and trial details remain unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%
- Check34 days agoChange DetectedNo substantive changes to the study details were observed between screenshots; core information remains the same. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%
- Check62 days agoChange DetectedAdded a government-funding/status notice and upgraded version to v3.2.0; removed the old v3.1.0 tag.SummaryDifference4%
- Check70 days agoChange DetectedNew version tag v3.1.0 added and several MedlinePlus topics removed (Drug Safety, Counterfeit Drugs, Pharmaceutical Preparations, Substandard Drugs); older version tag v3.0.2 removed. Core page content and topic scope updated accordingly.SummaryDifference0.6%
- Check84 days agoChange DetectedPage revision updated from v3.0.1 to v3.0.2; the 'Back to Top' link was removed.SummaryDifference0.2%
Stay in the know with updates to Ublituximab in RMS: Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Ublituximab in RMS: Clinical Trial page.